Recombinant Cyno u-Plasminogen Activator (uPA) Protein, CF

Catalog #: 11098-SE Datasheet / COA / SDS

His-tag

Catalog #	Availability	Size / Price	Qty
11098-SE-050

1 Image

All u-Plasminogen Activator (uPA)/Urokinase Proteins and Enzymes

Product Details

Reviews

Summary Product Datasheets Carrier Free Data Images Reconstitution Calculator Background Related Research Areas

Recombinant Cyno u-Plasminogen Activator (uPA) Protein, CF Summary

Product Specifications

Purity

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<0.10 EU per 1 μg of the protein by the LAL method.

Activity

Measured by its ability to cleave a peptide substrate, N-carbobenzyloxy-Gly-Gly-Arg-7-amido-4-methylcoumarin (Z-GGR-AMC). The specific activity is >2000 pmol/min/μg, as measured under the described conditions.

Source

Chinese Hamster Ovary cell line, CHO-derived cynomolgus monkey u-Plasminogen Activator (uPA)/Urokinase protein
Ser21-Leu430 with a C-terminal 10-His tag

Accession #

XP_05565501.1

N-terminal Sequence
Analysis

Lys155, Ile178, Met358

Predicted Molecular Mass

18 kDa (long A chain), 3 kDa (short A chain), 30 kDa (B chain)

SDS-PAGE

32-41 kDa (short form) and 48-59 kDa (long form), non-reducing conditions

Product Datasheets

11098-SE

Product Datasheet

COA

SDS

Carrier Free

What does CF mean?

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

What formulation is right for me?

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

11098-SE

Formulation	Supplied as a 0.2 μm filtered solution in HEPES, NaCl and CaCl₂.
Shipping	The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage:	Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt, -20 to -70 °C as supplied. 3 months, -20 to -70 °C under sterile conditions after opening.

Assay Procedure

Materials

Assay Buffer: 50 mM Tris, 0.01% (v/v) Tween® 20, pH 8.5
Recombinant Cynomolgus Monkey u-Plasminogen Activator (uPA)/Urokinase (rcyno uPA) (Catalog # 11098-SE)
Substrate: Z-Gly-Gly-Arg-AMC (Bachem, Catalog # I-1140), 10 mM stock in DMSO
F16 Black Maxisorp Plate (Nunc, Catalog # 475515)
Fluorescent Plate Reader (Model: SpectraMax M5 by Molecular Devices) or equivalent

Dilute rcyno uPA to 1 ng/µL in Assay Buffer.
Dilute Substrate to 400 µM in Assay Buffer.
Load 50 μL of 1 ng/µL rcyno uPA into a black well plate, and start the reaction by adding 50 µL of 400 µM Substrate. Include a Substrate Blank containing 50 µL of Assay buffer and 50 µL of 400 µM Substrate.
Read at excitation and emission wavelengths of 380 nm and 460 nm (top read), respectively, in kinetic mode for 5 minutes.
Calculate specific activity:
Specific Activity (pmol/min/µg) =
Adjusted V_max* (RFU/min) x Conversion Factor** (pmol/RFU)
amount of enzyme (µg)
*Adjusted for Substrate Blank
**Derived from calibration standard 7-amino, 4-Methyl Coumarin (Sigma, Catalog # A9891)

Per Reaction:

rcyno uPA: 0.05 µg
Substrate: 200 µM

Scientific Data

Enzyme Activity

View Larger

Recombinant Cynomolgous Monkey u-Plasminogen Activator (uPA)/Urokinase His-tag (Catalog # 11098-SE) is measured by its ability to cleave a peptide substrate, N-carbobenzyloxy-Gly-Gly-Arg-7-amido-4-methylcoumarin (Z-GGR-AMC).

Reconstitution Calculator

Background: u-Plasminogen Activator (uPA)/Urokinase

Urokinase Plasminogen Activator (uPA), also known as u-plasminogen activator or urokinase, is a highly-specific serine protease from the peptidase S1 family that cleaves plasminogen to form plasmin making it a key player in the plasminogen activator (PA) system (1, 2). In cancer, the PA system plays a commanding role in tumor growth, angiogenesis, tumor cell invasion, migration, and metastasis. Expression of uPA is minimal in normal cells but is increased several fold in tumor cells by extracellular stimuli elevated in cancer (3) and corresponds to poor outcomes in several types of cancer (2, 4-7). Therefore, uPA has been identified as an excellent target for therapeutic development through inhibition of protease activity or though inhibition of uPA-dependent signaling while in complex with uPA receptor (uPAR) (2, 7). The pro-enzyme of uPA is synthesized with an N-terminal signal peptide and processed into an active disulfide-linked two-chain molecule (2, 7-10). For the cynomolgous uPA, the B chain starting at Ile178 corresponds to the catalytic domain. Two forms of the A chain exist, one starting at Ser21 (the long form) and the other at Lys155 (the short form). While the B chain is common for both forms, the long and short A chains are unique to expected 48 kDa and 32 kDa two-chain forms, respectively. The long A chain contains an EGF-like domain and the kringle domain. The long A domain is reportedly responsible for the binding of the uPA receptor (uPAR) (2,7). Both high and low MW forms exist in the purified recombinant cyno uPA.

References

Ellis, V. (2004) in Handbook of Proteolytic Enzymes. Barrett, A.J. et al. eds. Academic Press, San Diego, pp.1677.
Mahmood, N. et al. (2018) Front Oncol. 8:24.
Nagamine, Y. et al. (2005) Thromb. Haemost. 93:661.
Duffy, M. and C. Duggan (2004) Clin. Biochem. 37:541.
Pappot, H. et al. (2006) Lung Cancer 51:193.
Taubert, H. et al. (2010) Br. J. Cancer 102:731.
Masucci, M.T. et al. (2022) Cancers. 14:498.
Riccio, A. et al. (1985) Nucleic Acids Res. 13:2759.
Nagai, M. et al. (1985) Gene 36:183.
Jacobs, P. et al. (1985) DNA 4:139.

Long Name

Urokinase-type Plasminogen Activator

Entrez Gene IDs

5328 (Human); 18792 (Mouse); 102135886 (Cynomolgus Monkey)

Alternate Names

ATF; EC 3.4.21; EC 3.4.21.73; plasminogen activator, urokinase; PLAU; uPA; u-PA; uPlasminogen Activator; u-Plasminogen Activator; urinary; Urokinase; urokinase-type plasminogen activator